Hospital Universitario de Toledo
About Hospital Universitario de Toledo
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Castilla-La Mancha Health Service
2
Eli Lilly and Company
2
Hoffmann-La Roche
2
Janssen Research & Development, LLC
2
Loxo Oncology, Inc.
2
Actelion
1
Spanish Breast Cancer Research Group
1
Umbria Bioengineering Technologies
1
Clinical Trials at Hospital Universitario de Toledo
During the past decade, Hospital Universitario de Toledo conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
2016-06-30
2023-06-30
Active, not recruiting
1,214
Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab
2019-05-31
2023-01-10
Terminated
88
A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
2020-07-07
2026-08-07
Recruiting
230
A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation
2020-05-28
2025-06-28
Active, not recruiting
165
Study of LOXO-305 Versus Investigator's Choice (IdelaR or BR) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
2021-03-09
2027-05-01
Recruiting
250
A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
2021-09-20
2027-01-01
Recruiting
600
Clinical Effects of Intermitent Continuous Glucose Monitoring in Type 1 Diabetes
2021-11-01
2022-05-06
Completed
1,121
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer
2022-03-11
2026-02-16
Recruiting
350
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Universitario de Toledo" #1 sponsor was "Castilla-La Mancha Health Service" with 2 trials, followed by "Eli Lilly and Company" with 2 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Loxo Oncology, Inc."
with 2 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de Toledo"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Pierre Fabre Laboratories" with 1 trials as a collaborator and "Puma Biotechnology, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Hospital Universitario de Toledo
According to Clinical.Site data, the most researched conditions in "Hospital Universitario de Toledo" are
"Chronic Lymphocytic Leukemia" (2 trials), "Small Lymphocytic Lymphoma" (2 trials), "Type 1 Diabetes" (2 trials), "Breast Cancer" (1 trials) and "Breast Neoplasm" (1 trials). Many other conditions were trialed in "Hospital Universitario de Toledo" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitario de Toledo
Most popular intervention types in "Hospital Universitario de Toledo" are "Drug" (10 trials), "Device" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Rituximab" (3 trials), "Bendamustine" (2 trials), "Venetoclax" (2 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitario de Toledo
The vast majority of trials in "Hospital Universitario de Toledo" are
12 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hospital Universitario de Toledo
Currently, there are NaN active trials in "Hospital Universitario de Toledo".
undefined are not yet recruiting,
7 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hospital Universitario de Toledo,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario de Toledo, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".